The human leukocyte antigen-presented ligandome of B lymphocytes.
about
An open-source computational and data resource to analyze digital maps of immunopeptidomesComprehensive Analysis of the Naturally Processed Peptide Repertoire: Differences between HLA-A and B in the ImmunopeptidomeMass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen PresentationBordetella pertussis proteins dominating the major histocompatibility complex class II-presented epitope repertoire in human monocyte-derived dendritic cellsToward Understanding the Essence of Post-Translational Modifications for the Mycobacterium tuberculosis ImmunoproteomeIn silico Derivation of HLA-Specific Alloreactivity Potential from Whole Exome Sequencing of Stem-Cell Transplant Donors and Recipients: Understanding the Quantitative Immunobiology of Allogeneic TransplantationAutoimmunity and tumor immunology: two facets of a probabilistic immune systemNaturally processed non-canonical HLA-A*02:01 presented peptides.The first step of peptide selection in antigen presentation by MHC class I molecules.Generation of CD20-specific TCRs for TCR gene therapy of CD20low B-cell malignancies insusceptible to CD20-targeting antibodies.Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry.Analysis of Major Histocompatibility Complex-Bound HIV Peptides Identified from Various Cell Types Reveals Common Nested Peptides and Novel T Cell Responses.MHC class I-associated peptides derive from selective regions of the human genome.Alloreactive cytotoxic T cells provide means to decipher the immunopeptidome and reveal a plethora of tumor-associated self-epitopes.Increased diversity of the HLA-B40 ligandome by the presentation of peptides phosphorylated at their main anchor residueTranslating DRiPs: MHC class I immunosurveillance of pathogens and tumors.Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD).Impact of genomic polymorphisms on the repertoire of human MHC class I-associated peptides.Sizing up the key determinants of the CD8(+) T cell response.Deciphering the MHC-associated peptidome: a review of naturally processed ligand data.The major histocompatibility complex class I immunopeptidome of extracellular vesicles.I've got algorithm: predicting tumor and autoimmune peptide targets for CD8+ T cells.Mass spectrometric analysis of the HLA class I peptidome of melanoma cell lines as a promising tool for the identification of putative tumor-associated HLA epitopes.Endoplasmic Reticulum Aminopeptidase 1 (ERAP1) Polymorphism Relevant to Inflammatory Disease Shapes the Peptidome of the Birdshot Chorioretinopathy-Associated HLA-A*29:02 Antigen.Exploration of peptides bound to MHC class I molecules in melanoma.Current tools for predicting cancer-specific T cell immunity.Peptide handling by HLA-B27 subtypes influences their biological behavior, association with ankylosing spondylitis and susceptibility to endoplasmic reticulum aminopeptidase 1 (ERAP1).Identification and characterisation of peptide binding motifs of six autoimmune disease-associated human leukocyte antigen-class I molecules including HLA-B*39:06.Building proteomic tool boxes to monitor MHC class I and class II peptides.CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytesHigh-sensitivity HLA class I peptidome analysis enables a precise definition of peptide motifs and the identification of peptides from cell lines and patients' sera.Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames.A CD22-reactive TCR from the T-cell allorepertoire for the treatment of acute lymphoblastic leukemia by TCR gene transfer.The SysteMHC Atlas project.Unique peptide-binding motif for Mamu-B*037:01: an MHC class I allele common to Indian and Chinese rhesus macaques.Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens.High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome.Minimal Information About an Immuno-Peptidomics Experiment (MIAIPE).A tissue-based draft map of the murine MHC class I immunopeptidomeAnalysis of the Minor Histocompatibility Antigen Landscape Based on the 1000 Genomes Project
P2860
Q28546655-C490EA60-1E95-4884-A520-E27E3A87D50DQ28548093-71A94C5D-4717-446E-837E-F38003DE9E58Q30002365-4873A841-1125-4ACF-9AF4-254C37FB7CB6Q33601872-6F0B6E08-5DE4-4F33-8FBE-0557B02326EBQ34024201-786F28DE-A0F4-4883-871C-8B4F3E24274FQ34462528-3B6E8B17-1684-4320-A97C-F7058EF959ADQ34537272-AAE70C2F-08E6-4F1C-80BC-F995D8D34B46Q35048892-6F742ACD-B80F-4573-AFCC-A6095C05E608Q35062805-CF2707EB-C6BE-447B-BED3-C76E21875EE3Q36173272-4310526E-F48F-493F-A82D-452A938CB91BQ36604367-13E4BEEC-9071-48A0-8791-5BE0F1B2B034Q37253013-3B77D9ED-F345-40A9-9153-E54BEFB27CF0Q37452154-C058300A-4915-46C9-B5CB-37EE84C2E2E2Q37475195-97BA193C-306D-47F6-A979-8C78C05BA797Q37563889-4774646C-45A3-4BFC-9AE6-67385E3A203CQ37644973-53F456B1-23F7-4D67-99EB-B2B17C089C14Q37674253-9CEF7292-47AA-42D3-8937-1230A284FAB0Q37718264-C15B9854-2FD0-42F6-9265-A166621B6889Q38602553-DC8695F6-2550-4135-8EA1-5D0C3F7C3982Q38653176-AEDFCEFD-BEBF-42AD-9815-EA60B3A97B16Q38693646-527A2F89-F433-4FC7-B9ED-5A66C27CD232Q38731152-55B1F708-2781-4E09-98EF-08C395515998Q38740015-09BEBE5D-EFDF-4512-898B-CD4900B7349FQ38884742-9D023FA8-0353-4205-B887-E44F882C0317Q38913724-30017B18-F392-49FD-9C67-8D716C16F9AFQ38953021-BAC657FE-C226-4A21-90AE-C842FF114BC2Q38959953-F12A7C67-B049-4547-96C4-A9408AF2EE83Q38963058-EA6B23CF-7D49-4D8B-8162-0B7EC735ED57Q39032610-70E8F2B0-C9C5-4824-925B-3FD01A6AC722Q39042122-CFF9641D-24EB-4447-8427-BF2D595234F8Q41410124-C12A89EF-8D56-4707-81E8-193957061260Q41906355-20CE69C6-E34A-4587-924E-8F07C9B33FE4Q41961217-E3B43BFC-5A60-4C68-B315-94974A27B87BQ41990341-337DD5C2-B284-41D0-A296-1B1E9971B1C9Q45805093-D6BD6930-0436-4E93-A837-D7BED8AE724EQ49483662-0F355FC3-CCE0-4F11-8983-3FA0CA1968ADQ49836890-261D57A9-21E2-4EC8-8C66-42BC23573B8AQ54201155-F1C96346-0A29-4367-BA7F-B9A063EB910CQ57170495-44B27C67-2ADD-4C48-9A32-A378A110A43BQ58773669-D7761D1F-D16F-4AF6-9013-17460A4D7D00
P2860
The human leukocyte antigen-presented ligandome of B lymphocytes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The human leukocyte antigen-presented ligandome of B lymphocytes.
@en
The human leukocyte antigen-presented ligandome of B lymphocytes.
@nl
type
label
The human leukocyte antigen-presented ligandome of B lymphocytes.
@en
The human leukocyte antigen-presented ligandome of B lymphocytes.
@nl
prefLabel
The human leukocyte antigen-presented ligandome of B lymphocytes.
@en
The human leukocyte antigen-presented ligandome of B lymphocytes.
@nl
P2093
P2860
P356
P1476
The human leukocyte antigen-presented ligandome of B lymphocytes.
@en
P2093
Arnoud H de Ru
Chopie Hassan
J H Frederik Falkenburg
Jack A M Leunissen
Jan Wouter Drijfhout
Michel G D Kester
Mirjam H M Heemskerk
Pleun Hombrink
P2860
P304
P356
10.1074/MCP.M112.024810
P577
2013-03-12T00:00:00Z